Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 221-240
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Vineet Chhangani Managing Director - Technology Investment Banking at Morgan Stanley | New York, United States | Corporate VCPrivate equity | FinTechHardware | View profile | |
 Mark Marcus Investor at New Enterprise Associates (NEA) | Silver Spring, United States | Venture capital | AICommerce | View profile | |
 Shan Shan Wang Associate Director at RA Capital Management | Boston, United States | Private equityVenture capital | FinTechHealthcare | View profile | |
 Randy Berholtz Venture Capitalist at Mesa Verde Venture Partners | Rancho Santa Fe, United States | Venture capital | Healthcare | View profile | |
 Jeannine Caruso Investment Committee Chair (a/o 2025) at The Helmsley Charitable Trust | Greenwich, United States | Family Office | Healthcare | View profile | |
 Adele Oliva Founding Partner at 1315 Capital | Philadelphia, United States | Private equityVenture capital | AICommerce | View profile | |
 Camille Crueghe Investor at Fonds de solidarité FTQ | Montreal, Canada | Private equityVenture capital | AIClimate | View profile | |
 Hello Founders Founder Operating System at LVX | Bengaluru, India | Syndicate / Angel groupVenture capital | HealthcareSaaS | View profile | |
 Cillian King Investor at Eqt Life Sciences | Amsterdam, Netherlands | Private equityVenture capital | Healthcare | View profile | |
 Lan Jiang Partner at Lux Capital | Menlo Park, United States | Venture capital | AIClimate | View profile | |
 John Prufeta Founder & General Partner at Medical Excellence Capital | New York City, United States | Venture capital | Healthcare | View profile | |
 Michael H. Lee Investor at Marshall Wace | New York, United States | Private equityVenture debt | FinTechHealthcare | View profile | |
 Sala Fitt Director, Private Credit at M&g Investments | London, United Kingdom | Private equityVenture debt | CommerceFinTech | View profile | |
 Jim Trenkle Partner, Venture Investments at Novo Holdings | San Francisco, United States | Family OfficePrivate equity | FinTechHardware | View profile | |
 Alex Lusty Gabriel Investment Syndicate at Gabriel Investments | Edinburgh, United Kingdom | Venture capital | ClimateCommerce | View profile | |
 David Pringle Managing Director at Morgan Stanley | Los Angeles, United States | Corporate VCPrivate equity | FinTechHardware | View profile | |
 Fouad Azzam Partner at Eqt Life Sciences | Boston, United States | Private equityVenture capital | Healthcare | View profile | |
 Norma Cernadas Investor at American Chemical Society | Washington, United States | Government-backed | ClimateEducation | View profile | |
 John de Koning Partner at Eqt Life Sciences | Amsterdam, Netherlands | Private equityVenture capital | Healthcare | View profile | |
 Elisa Miller-Out Managing Partner at Chloe Capital | Ithaca, United States | Family OfficeVenture capital | AIClimate | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal